{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:50:21Z","timestamp":1782143421022,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s41030-026-00358-x","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:57:30Z","timestamp":1774684650000},"page":"573-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Thailand: Epidemiological Data Update"],"prefix":"10.1007","volume":"12","author":[{"given":"Karan","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruangwit","family":"Thamaree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe H.","family":"Kyaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iustina","family":"Chirila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fernando","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Yarnoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasisopin","family":"Kiertiburanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"358_CR1","unstructured":"Worldometer. Coronavirus Tracker\u2014Thailand 2024 [updated April 13, 2024]. https:\/\/www.worldometers.info\/coronavirus\/country\/thailand\/. Accessed 15 Nov 2025."},{"key":"358_CR2","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard 2023. https:\/\/covid19.who.int\/table. Accessed 15 Nov 2025."},{"issue":"7","key":"358_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10071310","volume":"10","author":"K Duangchaemkarn","year":"2022","unstructured":"Duangchaemkarn K, Boonchieng W, Wiwatanadate P, Chouvatut V. SARIMA model forecasting performance of the COVID-19 daily statistics in Thailand during the Omicron variant epidemic. Healthc Basel. 2022;10(7):1310.","journal-title":"Healthc Basel"},{"issue":"7","key":"358_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071024","volume":"10","author":"R Suphanchaimat","year":"2022","unstructured":"Suphanchaimat R, Teekasap P, Nittayasoot N, Phaiyarom M, Cetthakrikul N. Forecasted trends of the new COVID-19 epidemic due to the Omicron variant in Thailand, 2022. Vaccines (Basel). 2022;10(7):1024.","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"358_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10122123","volume":"10","author":"N Nittayasoot","year":"2022","unstructured":"Nittayasoot N, Suphanchaimat R, Thammawijaya P, et al. Real-world effectiveness of COVID-19 vaccines against severe outcomes during the period of Omicron predominance in Thailand: a test-negative nationwide case-control study. Vaccines (Basel). 2022;10(12):2123.","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"358_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284130","volume":"18","author":"K Intawong","year":"2023","unstructured":"Intawong K, Chariyalertsak S, Chalom K, et al. Waning vaccine response to severe COVID-19 outcomes during Omicron predominance in Thailand. PLoS ONE. 2023;18(5):e0284130.","journal-title":"PLoS ONE"},{"key":"358_CR7","unstructured":"Thailand Ministry of Public Health. Thailand\u2019s COVID-19 Vaccine. https:\/\/ddc.moph.go.th\/vaccine-covid19\/. Accessed 15 Nov 2025."},{"issue":"1","key":"358_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/14760584.2023.2265460","volume":"22","author":"K Thakkar","year":"2023","unstructured":"Thakkar K, Spinardi J, Kyaw MH, et al. Modelling the potential public health impact of different vaccination strategies with an omicron-adapted bivalent vaccine in Thailand. Expert Rev Vaccines. 2023;22(1):860\u201370.","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"358_CR9","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1097\/JS9.0000000000000513","volume":"109","author":"R Sarker","year":"2023","unstructured":"Sarker R, Roknuzzaman ASM, Hossain MJ, Bhuiyan MA, Islam MR. The WHO declares COVID-19 is no longer a public health emergency of international concern: benefits, challenges, and necessary precautions to come back to normal life. Int J Surg. 2023;109(9):2851\u20132.","journal-title":"Int J Surg"},{"issue":"1","key":"358_CR10","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/13696998.2022.2071427","volume":"25","author":"M Di Fusco","year":"2022","unstructured":"Di Fusco M, Marczell K, Deger KA, et al. Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States. J Med Econ. 2022;25(1):605\u201317.","journal-title":"J Med Econ"},{"key":"358_CR11","unstructured":"National Statistical Office Thailand. Number of Population by Age, Sex, Region and Province 2021. http:\/\/statbbi.nso.go.th\/staticreport\/page\/sector\/en\/01.aspx. Accessed 15 Nov 2025."},{"issue":"8","key":"358_CR12","doi-asserted-by":"publisher","first-page":"e1003","DOI":"10.1016\/S2214-109X(20)30264-3","volume":"8","author":"A Clark","year":"2020","unstructured":"Clark A, Jit M, Warren-Gash C, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020;8(8):e1003\u201317.","journal-title":"Lancet Glob Health"},{"issue":"8","key":"358_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/jamainternmed.2024.1640","volume":"184","author":"SY Tartof","year":"2024","unstructured":"Tartof SY, Slezak JM, Frankland TB, et al. Estimated effectiveness of the BNT162b2 XBB vaccine against COVID-19. JAMA Intern Med. 2024;184(8):932\u201340.","journal-title":"JAMA Intern Med"},{"key":"358_CR14","unstructured":"Department of Disease Control MoPHoT. COVID-19 Situation Updated Weekly in API Format (JSON\/CSV Data Format) [translated from Thai] 2025. https:\/\/covid19.ddc.moph.go.th\/. Accessed 15 Nov 2025."},{"key":"358_CR15","doi-asserted-by":"crossref","unstructured":"Mustapha M, Togo K, Volkman H, et al. Under-reporting of SARS-CoV-2 infections in 27 countries, 2020\u20132022. SSRN. 2024.","DOI":"10.2139\/ssrn.5014145"},{"issue":"12","key":"358_CR16","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S1473-3099(22)00692-2","volume":"22","author":"SY Tartof","year":"2022","unstructured":"Tartof SY, Slezak JM, Puzniak L, et al. BNT162b2 vaccine effectiveness against SARS-CoV-2 OMICRON BA.4 and BA.5. Lancet Infect Dis. 2022;22(12):1663\u20135.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"358_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-2600(22)00101-1","volume":"10","author":"SY Tartof","year":"2022","unstructured":"Tartof SY, Slezak JM, Puzniak L, et al. Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the Omicron and Delta variants in a large health system in the USA: a test-negative case-control study. Lancet Respir Med. 2022;10(7):689\u201399.","journal-title":"Lancet Respir Med"},{"issue":"8","key":"358_CR18","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1473-3099(23)00122-6","volume":"23","author":"R Arbel","year":"2023","unstructured":"Arbel R, Peretz A, Sergienko R, et al. Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study. Lancet Infect Dis. 2023;23(8):914\u201321.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"358_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.15585\/mmwr.mm7205e1","volume":"72","author":"R Link-Gelles","year":"2023","unstructured":"Link-Gelles R. Early estimates of bivalent mRNA booster dose vaccine effectiveness in preventing symptomatic SARS-CoV-2 infection attributable to Omicron BA.5- and XBB\/XBB.1.5-related sublineages among immunocompetent adults\u2014increasing community access to testing program, United States, December 2022\u2013January 2023. MMWR Morb Mortal Wkly Rep. 2023;72(5):119\u201324.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"358_CR20","doi-asserted-by":"crossref","unstructured":"Surie D, Bonnell L, Adams K, et al. Effectiveness of monovalent mRNA vaccines against COVID-19-associated hospitalization among immunocompetent adults during BA.1\/BA.2 and BA.4\/BA.5 predominant periods of SARS-CoV-2 Omicron variant in the United States\u2014IVY Network, 18 States, December 26, 2021\u2013August 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(42):1327\u201334.","DOI":"10.15585\/mmwr.mm7142a3"},{"issue":"5152","key":"358_CR21","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.15585\/mmwr.mm715152e2","volume":"71","author":"D Surie","year":"2022","unstructured":"Surie D. Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19-associated hospitalization among immunocompetent adults aged\u2265 65\u00a0years\u2014IVY Network, 18 states, September 8\u2013November 30, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(5152):1625\u201330.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"358_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.47102\/annals-acadmedsg.V52N10p522","volume":"52","author":"J Li","year":"2023","unstructured":"Li J, Nadua K, Chong CY, Yung CF. Long COVID prevalence, risk factors and impact of vaccination in the paediatric population: a survey study in Singapore. Ann Acad Med Singap. 2023;52(10):522\u201332.","journal-title":"Ann Acad Med Singap"},{"key":"358_CR23","doi-asserted-by":"crossref","unstructured":"Trading Economics. Thailand Consumer Price Index (CPI) 2023. https:\/\/tradingeconomics.com\/thailand\/consumer-price-index-cpi. Accessed 15 Nov 2025.","DOI":"10.69645\/DSDC8304"},{"key":"358_CR24","unstructured":"Ministry of Public Health of Thailand. Health Services Fees for Facilities under the Ministry of Public Health (A.D 2025): RT-PCR for SAR-COV-2. 2025."},{"key":"358_CR25","unstructured":"World Bank Group. Government Expenditure per Student, Secondary (% of GDP per Capita) - Malaysia 2020 [updated February 2020]. https:\/\/data.worldbank.org\/indicator\/SE.XPD.SECO.PC.ZS?locations=MY. Accessed 15 Nov 2025."},{"key":"358_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s41669-020-00250-7","volume":"5","author":"D Sharma","year":"2021","unstructured":"Sharma D, Aggarwal AK, Downey LE, Prinja S. National healthcare economic evaluation guidelines: a cross-country comparison. Pharmacoecon Open. 2021;5:349\u201364.","journal-title":"Pharmacoecon Open"},{"key":"358_CR27","volume":"26","author":"K Trerayapiwat","year":"2022","unstructured":"Trerayapiwat K, Jinatongthai P, Vathesatogkit P, et al. Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand. The Lancet Regional Health. 2022;26:100503.","journal-title":"The Lancet Regional Health"},{"issue":"5","key":"358_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/0272989X12454579","volume":"32","author":"DM Eddy","year":"2012","unstructured":"Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB. Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force\u20137. Med Decis Making. 2012;32(5):733\u201343.","journal-title":"Med Decis Making"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-026-00358-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-026-00358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:24:39Z","timestamp":1782141879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-026-00358-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1007\/s41030-026-00358-x","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Karan Thakkar, Ruangwit Thamaree, Moe H Kyaw, Iustina Chirila, and Carlos Fernando Mendoza are employees of Pfizer and may hold stock or stock options of Pfizer. Ben Yarnoff and Josie Dodd are employees of PPD Evidera Health Economics & Market Access, Thermo Fisher Scientific, which received financial support from Pfizer in connection with the study and the development of this manuscript. Sasisopin Kiertiburanakul has no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}